{{Rsnum
|rsid=4920608
|Gene=ATP13A2
|Chromosome=1
|position=16992792
|Orientation=plus
|GMAF=0.4573
|Gene_s=ATP13A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 9.7 | 46.0 | 44.2
| HCB | 46.3 | 46.3 | 7.4
| JPT | 50.5 | 40.5 | 9.0
| YRI | 39.7 | 45.9 | 14.4
| ASW | 37.5 | 48.2 | 14.3
| CHB | 46.3 | 46.3 | 7.4
| CHD | 41.3 | 46.8 | 11.9
| GIH | 25.7 | 46.5 | 27.7
| LWK | 36.4 | 52.7 | 10.9
| MEX | 26.8 | 48.2 | 25.0
| MKK | 29.5 | 51.3 | 19.2
| TSI | 18.6 | 42.2 | 39.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=22285144
|Title=ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}